206 related articles for article (PubMed ID: 21054)
21. Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.
Lima JJ; Haughey DB; Leier CV
J Pharmacokinet Biopharm; 1984 Jun; 12(3):289-313. PubMed ID: 6502472
[TBL] [Abstract][Full Text] [Related]
22. The stereoselective disposition of disopyramide in the dog.
Giacomini KM; Giacomini JC; Swezey SE; Harrison DC; Nelson WL; Burke TR; Blaschke TF
J Cardiovasc Pharmacol; 1980; 2(6):825-32. PubMed ID: 6160331
[TBL] [Abstract][Full Text] [Related]
23. Disopyramide pharmacokinetics in patients with acute myocardial infarction.
Pentikäinen PJ; Huikuri H; Jounela AJ; Wilen G
Eur J Clin Pharmacol; 1985; 28(1):45-51. PubMed ID: 3987785
[TBL] [Abstract][Full Text] [Related]
24. Disopyramide pharmacokinetics during recovery from myocardial infarction.
Bryson SM; Cairns CJ; Whiting B
Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444
[TBL] [Abstract][Full Text] [Related]
25. Disopyramide kinetics in patients with acute myocardial infarction.
Ilett KF; Madsen BW; Woods JD
Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
[TBL] [Abstract][Full Text] [Related]
26. The renal clearance of disopyramide after bolus intravenous injection.
Lawrence JR; Bryson SM; Sumner DJ; Campbell BC; Whiting B
Biopharm Drug Dispos; 1979; 1(2):51-7. PubMed ID: 552861
[TBL] [Abstract][Full Text] [Related]
27. Disposition kinetics of disopyramide in patients with renal insufficiency.
Shen DD; Cunningham JL; Shudo I; Azarnoff DL
Biopharm Drug Dispos; 1980; 1(3):133-40. PubMed ID: 7448340
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.
Landmark K; Bredesen JE; Thaulow E; Simonsen S; Amlie JP
Eur J Clin Pharmacol; 1981 Feb; 19(3):187-92. PubMed ID: 7215416
[TBL] [Abstract][Full Text] [Related]
29. Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tablets.
Graffner C; Lagerström PO; Lundborg PN; Rönn OF
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):414-9. PubMed ID: 7298249
[TBL] [Abstract][Full Text] [Related]
30. Elimination kinetics and urinary excretion of disopyramide in human healthy volunteers.
Bonde J; Jensen NM; Pedersen LE; Graudal NA; Angelo HR; Kampmann JP
Pharmacol Toxicol; 1988 May; 62(5):298-301. PubMed ID: 3413032
[TBL] [Abstract][Full Text] [Related]
31. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
Jounela AJ; Pentikäinen PJ; Oksanen K
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
[TBL] [Abstract][Full Text] [Related]
32. Human pharmacokinetics and metabolism of disopyramide enantiomers.
Le Corre P; Gibassier D; Sado P; Le Verge R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
[TBL] [Abstract][Full Text] [Related]
33. Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis.
Sevka MJ; Matthews SJ; Nightingale CH; Izard MW; Fieldman A; Chow MS
Clin Pharmacol Ther; 1981 Mar; 29(3):322-6. PubMed ID: 7471602
[TBL] [Abstract][Full Text] [Related]
34. Clinical pharmacokinetics of disopyramide.
Siddoway LA; Woosley RL
Clin Pharmacokinet; 1986; 11(3):214-22. PubMed ID: 3524956
[TBL] [Abstract][Full Text] [Related]
35. Bioavailability of disopyramide in normal volunteers using unbound concentration.
Braun J; Sörgel F; Gluth WP; Oie S
Eur J Clin Pharmacol; 1987; 32(6):625-9. PubMed ID: 3653232
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
[TBL] [Abstract][Full Text] [Related]
37. Plasma binding of disopyramide and mono-N-dealkyldisopyramide.
Bredesen JE; Pike E; Lunde PK
Br J Clin Pharmacol; 1982 Nov; 14(5):673-6. PubMed ID: 7138747
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal dialysis of disopyramide in healthy subjects.
Arimori K; Kawano H; Nakano M
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
[TBL] [Abstract][Full Text] [Related]
39. The pharmacokinetics and protein binding of disopyramide in pigs.
Pedersen LE; Hermansen K; Olesen HP; Rasmussen SN
Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):282-8. PubMed ID: 3716823
[TBL] [Abstract][Full Text] [Related]
40. Kinetics and dynamics of disopyramide and its dealkylated metabolite in healthy subjects.
Chiang WT; von Bahr C; Calissendorff B; Dahlqvist R; Emilsson H; Magnusson A; Schenck-Gustafsson K
Clin Pharmacol Ther; 1985 Jul; 38(1):37-44. PubMed ID: 4006374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]